搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Yahoo Finance
8 小时
X4 Pharmaceuticals Announces Positive Results from Completed Six-Month Phase 2 Trial of ...
13, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare ...
News Medical on MSN
7 天
Advances in neutropenia research could pave the way for better treatments
Neutropenia is a condition in which there are not enough neutrophils, a type of white blood cell, in the blood.
manilatimes
13 分钟
X4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update
BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people ...
AlphaGalileo
7 天
Advancing Neutropenia research
Neutropenia is a condition in which there are not enough neutrophils, a type of white blood cell, in the blood. Neutrophils ...
腾讯网
1 天
升白针出现的不良反应,哪些需要格外重视?
粒细胞集落刺激因子(granulocyte colony stimulating factor,G-CSF)也称为集落刺激因子 3(colony stimulating factor 3,CSF3),是一种含有 174 个 氨基酸的糖蛋白(19.6 ...
9 天
Neutropenia Treatment Market to hit USD 20.8 billion by 2032, says Global Market Insights Inc.
Neutropenia treatment industry is projected to witness a CAGR of 4.1% during the period 2024-2032. This growth can be ...
腾讯网
21 天
接受化疗和造血干细胞移植患儿侵袭性真菌病的管理,一文了解~
作者:蓝鲸晓虎免疫功能低下的患者发生细菌、病毒和真菌感染等感染性并发症的风险较高,为患者带来严重痛苦,延长治疗时间。感染是血液系统患儿死亡的重要原因,发生感染时常需中止化疗。本文以近年来发布的指南为依据,总结接受化疗或接受造血干细胞移植(HSCT)患 ...
Cure Today
21 小时
Managing Trodelvy’s Side Effects Through Dose Adjustment
An expert told CURE that Trodelvy's side effects, such as neutropenia and fatigue, can often be managed through dose ...
Medscape
5 天
Vancomycin-induced Neutropenia
Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration-related and provide clinicians with feasible treatment alternatives.
FierceBiotech
21 小时
Syndax's small molecule underwhelms investors in midstage acute leukemia trial, sending ...
Overall, more than 10% of patients experienced TRAEs of grade 3 level or higher, including QTc prolongation (21%); anemia (14 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈